Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a global leader in robotic-assisted surgery, best known for its da Vinci surgical systems. The company designs, manufactures, and markets robotic platforms that enable minimally invasive procedures across a range of specialties including urology, gynecology, thoracic, and general surgery. By combining advanced instrumentation, 3D visualization, and computer-assisted control, Intuitive’s systems allow surgeons to perform complex operations with enhanced precision and dexterity.

Intuitive generates revenue primarily through three streams: (1) recurring sales of instruments and accessories used with each procedure, (2) system placements (sales or leases of da Vinci robots), and (3) services and training contracts. The majority of revenue comes from recurring sources, as each procedure consumes single-use instruments. The company also benefits from a growing installed base, which drives higher procedure volumes and consumable sales. In the latest fiscal year, total revenue reached approximately $10.6 billion.

The company operates in the medical instruments and supplies industry within the healthcare sector. Intuitive holds a dominant position in the robotic surgery market, with over 9,000 da Vinci systems installed worldwide. Its main competitors include Medtronic (Hugo RAS), Johnson & Johnson (Ottava), and Stryker (Mako), but Intuitive maintains a significant lead in clinical adoption, regulatory approvals, and procedural breadth. High switching costs and a strong ecosystem of training and support create substantial barriers for competitors.

Intuitive’s primary customers are hospitals and surgical centers, which purchase or lease its systems and buy consumables for procedures. The end users are surgeons and surgical teams who undergo specialized training. Geographically, the largest market is the United States, accounting for roughly two-thirds of revenue, followed by Europe and Asia. The company is expanding in emerging markets, particularly in China and India, where adoption of robotic surgery is increasing.

An auto-generated descriptive profile based on company data, for informational purposes only.